Novo Nordisk A/S
F:NOV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novo Nordisk A/S
F:NOV
|
DK |
|
J
|
JPMorgan Chase & Co
SWB:CMC
|
US |
Multiples-Based Value
The Multiples-Based Value for
Novo Nordisk A/S (NOV) under the Base Case is 80.22 EUR.
Compared with the current market price of 44.1 EUR, the stock appears
Undervalued by 45% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.